61360007: Polymyxin B sulfate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with antibacterial mechanism of action (substance)\Polymyxin\Polymyxin B sulfate (substance)

\Drug or medicament (substance)\Anti-infective agent (substance)\Substance with antibacterial mechanism of action (substance)\Polymyxin\Polymyxin B sulfate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Peptide\Cyclic peptide\Polymyxin\Polymyxin B sulfate (substance)

\Organic compound\Organic cyclic compound\Polycyclic compound\Cyclic peptide\Polymyxin\Polymyxin B sulfate (substance)
\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide (substance)\Peptide\Cyclic peptide\Polymyxin\Polymyxin B sulfate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Polymyxin B sulfate (substance)	Is a	Product containing polymyxin B (medicinal product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate (substance)	Is a	Polymyxin B	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate (substance)	Is a	Polymyxin	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate (substance)	Is a	allergène médicamenteux	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate (substance)	Is modification of (attribute)	Polymyxin B	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate (substance)	Has disposition	Antibacterial (disposition)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Polymyxin B sulf [systemic]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulf [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate [skin]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin b sulfate 100% powder	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+trimethoprim eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+bacitracin zinc eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+trimethoprim eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate+bacitracin zinc 10,000u/500u ophthalmic ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/3.5gm/10000unt ointment (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bacitracin zinc + neomycin sulfate + polymyxin b sulfate 400unt/5mg/10000unt ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bacitracin zinc + polymyxin b sulphate 500unt/10000unt ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulfate + polymyxin b sulfate 0.1%wv/ns/10000unt ointment (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Dexamethasone + neomycin sulfate + polymyxin b sulphate 0.1%wv/ns/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Gramicidin + neomycin sulfate + polymyxin b sulphate 0.025mg/1.75mg/10000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/5mg/1.6mg suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulfate 10mg/5mg/10000unt sol	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone+neomycin sulfate+polymyxin b sulphate 10mg/5ns/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/10000unt suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone + neomycin sulfate + polymyxin b sulphate 10mg/7.5mg/1000unt solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Hydrocortisone acetate + neomycin sulfate + polymyxin b sulfate 5mg/3.5mg/10000unit cream	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Neomycin sulfate + polymyxin b sulfate + prednisolone acetate 0.35%/10000unt/0.5%wv suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin b sulfate + trimethoprim sulfate 10000unt/ns solution (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing neomycin sulfate and polymyxin B sulfate and prednisolone acetate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing gramicidin and neomycin sulfate and polymyxin b sulfate in ophthalmic dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin b sulfate + trimethoprim sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
médicament contenant dexaméthasone et néomycine et polymyxine B	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Bacitracin zinc + polymyxin b sulfate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B sulfate 500,000u powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing hydrocortisone and neomycin sulfate and polymyxin B sulfate and zinc bacitracin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)
Polymyxin B (as polymyxin B sulfate) 500000 unit powder for solution for injection vial	Has precise active ingredient	True	Polymyxin B sulfate (substance)	Inferred relationship	Existential restriction modifier (core metadata concept)	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
101950019	Polymyxin B sulfate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
498992017	Polymyxin B sulphate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
800413012	Polymyxin B sulfate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
101950019	Polymyxin B sulfate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
498992017	Polymyxin B sulphate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
800413012	Polymyxin B sulfate (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
43161000188110	polymyxine B sulfate	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
834511000172117	sulfate de polymyxine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
43161000188110	polymyxine B sulfate	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
834511000172117	sulfate de polymyxine B	fr	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module